Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTISS in facelift
NCT00999141Phase 3Completed
- Sponsor
- Baxter
- Start
- Sep 2009
- Primary completion
- Dec 2009
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in facial rhytidectomy comparing ARTISS with Standard of Care (2 arms). Primary endpoints: Total Volume of Drainage on Each Side of the Face at 24 hours and Number of AEs Related to the Investigational Product at 14 days. Started Sep 2009; status: completed.
02
Drugs
tisseel
03
Conditions
facial rhytidectomy
Beyond the preview
Go deeper on NCT00999141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999141.